(5 references)-
- 抗原 See all CD81 抗体
- CD81
-
适用
- 人, 兔, Cat
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CD81 antibody is conjugated to PE
-
应用范围
- Flow Cytometry (FACS)
- 特异性
- This antibody CD81, a 25 kDa member of the tetraspanin family, expressed on majority of cells.
- 交叉反应 （详细）
- Species reactivity (tested):Human, Feline (Cat), Rabbit
- 免疫原
- MOLT-4 (human T-ALL cell line)
- 克隆位点
- M38
- 亚型
- IgG1
- Top Product
- Discover our top product CD81 Primary Antibody
-
anti-CD81 (CD81) antibody
KO Validated CD81 适用: 人 FACS, WB, IF, IHC (p), ICC, BP 宿主: 兔 Polyclonal unconjugated
anti-CD81 (CD81) (AA 1-100) antibodyCD81 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-CD81 (CD81) antibodyCD81 适用: 人 FACS, WB, IHC, ELISA 宿主: 兔 Monoclonal 9F7 unconjugated Recombinant Antibody
anti-CD81 (CD81) antibodyCD81 适用: 人, 小鼠, 大鼠 FACS, WB, IHC, IF, Func, StM 宿主: 小鼠 Monoclonal 1-3-3-22 unconjugated
anti-CD81 (CD81) antibodyCD81 适用: 人, 小鼠, 大鼠 ELISA, Coat 宿主: 兔 Monoclonal C81-2885R unconjugated Recombinant Antibody
anti-CD81 (CD81) antibodyCD81 适用: 人, 兔, Cat FACS, WB, IP, IHC (p), ICC 宿主: 小鼠 Monoclonal M38 unconjugated
anti-CD81 (CD81) antibody (FITC)CD81 适用: 人, 兔, Cat FACS 宿主: 小鼠 Monoclonal M38 FITC
anti-CD81 (CD81) antibody (PE)CD81 适用: 人, 兔, Cat FACS 宿主: 小鼠 Monoclonal M38 PE
anti-CD81 (CD81) antibodyCD81 适用: 人 FACS, cELISA 宿主: 大鼠 Monoclonal QV-6A8-S3 unconjugated
anti-CD81 (CD81) antibodyCD81 适用: 人, 兔, Cat FACS, WB, IP, IHC (p), Func, ICC 宿主: 小鼠 Monoclonal M38 unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- Phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2 % (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- DO NOT FREEZE! This product is photosensitive and should be protected from light.
- 储存条件
- 4 °C
-
-
: "Differential subcellular localization of phosphorylated neurofilament and tau proteins in degenerating neurons of the human entorhinal cortex." in: Neuroreport, Vol. 14, Issue 7, pp. 929-33, (2003) (PubMed).
: "Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes." in: The Journal of biological chemistry, Vol. 273, Issue 32, pp. 20121-7, (1998) (PubMed).
: "Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 155, Issue 3, pp. 1229-39, (1995) (PubMed).
: "C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 151, Issue 11, pp. 6470-81, (1994) (PubMed).
: "Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 138, Issue 12, pp. 4150-8, (1987) (PubMed).
-
: "Differential subcellular localization of phosphorylated neurofilament and tau proteins in degenerating neurons of the human entorhinal cortex." in: Neuroreport, Vol. 14, Issue 7, pp. 929-33, (2003) (PubMed).
-
- 抗原
- CD81
- 别名
- CD81 / TAPA1 (CD81 产品)
- 背景
- CD81 (TAPA-1), a member of the tetraspanin family, is expressed on virtually all nucleated cells, but above all on germinal center B cells. CD81 forms complexes with other tetraspanin proteins, integrins, coreceptors, MHC class I and II molecules, and influences adhesion, morphology, activation, proliferation and differentiation of B, T and other cells - e.g. in muscles CD81 promotes cell fusion and myotube maintenance. CD81 has been also identified as a receptor for the hepatitis C virus.Synonyms: 26 kDa cell surface protein TAPA-1, Target of the antiproliferative antibody 1
- 基因ID
- 975
- NCBI登录号
- NP_004347
- UniProt
- P60033
- 途径
- Inositol Metabolic Process, Hepatitis C
-
You are here:
